Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on March 31, 2003

Circulation. 2003
Published online before print March 31, 2003, doi: 10.1161/01.CIR.0000065226.24159.E9
A more recent version of this article appeared on April 22, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/15/1985    most recent
01.CIR.0000065226.24159.E9v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by St John Sutton, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by St John Sutton, M. G.
Related Collections
Right arrow Electrophysiology
Right arrow Other heart failure
Right arrow Congestive
Right arrow Remodeling
Right arrow Echocardiography

Submitted on December 23, 2002
Accepted on February 7, 2003

Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart Failure

Martin G. St John Sutton MD*, Ted Plappert , William T. Abraham MD, Andrew L. Smith MD, David B. DeLurgio MD, Angel R. Leon MD, Evan Loh MD, Dusan Z. Kocovic MD, Westby G. Fisher MD, Myrvin Ellestad MD, John Messenger MD, Kristin Kruger , Kathryn E. Hilpisch , Michael R.S. Hill PhD, and for the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group

From the University of Pennsylvania Medical Center, Philadelphia, Pa (M.G.S.J.S., T.P., E.L., D.Z.K.); the University of Kentucky College of Medicine, Lexington, Ky (W.T.A., W.G.F.); Emory University/Crawford Long Hospital, Atlanta, Ga (A.L.S., D.B.D., A.R.L.); Long Beach Memorial Medical Center, Long Beach, Calif (M.E., J.M.); and Medtronic, Inc, Minneapolis, Minn (K.K., K.E.H., M.R.S.H.).

* To whom correspondence should be addressed. E-mail: suttonm{at}mail.med.upenn.edu.

Background--Cardiac resynchronization therapy (CRT) has recently emerged as an effective treatment for patients with moderate to severe systolic heart failure and ventricular dyssynchrony. The purpose of the present study was to determine whether improvements in left ventricular (LV) size and function were associated with CRT.

Methods and Results--Doppler echocardiograms were obtained at baseline and at 3 and 6 months after therapy in 323 patients enrolled in the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) trial. Of these, 172 patients were randomized to CRT on and 151 patients to CRT off. Measurements were made of LV end-diastolic and end-systolic volumes, ejection fraction, LV mass, severity of mitral regurgitation (MR), peak transmitral velocities during early (E-wave) and late (A-wave) diastolic filling, and the myocardial performance index. At 6 months, CRT was associated with reduced end-diastolic and end-systolic volumes (both P<0.001), reduced LV mass (P<0.01), increased ejection fraction (P<0.001), reduced MR (P<0.001), and improved myocardial performance index (P<0.001) compared with control. {beta}-Blocker treatment status did not influence the effect of CRT. Improvements with CRT were greater in patients with a nonischemic versus ischemic cause of heart failure.

Conclusions--CRT in patients with moderate-to-severe heart failure who were treated with optimal medical therapy is associated with reverse LV remodeling, improved systolic and diastolic function, and decreased MR. LV remodeling likely contributes to the symptomatic benefits of CRT and may herald improved longer-term survival.


Key words: heart failure • echocardiography • remodeling • pacing




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
C. Daubert, M. R. Gold, W. T. Abraham, S. Ghio, C. Hassager, G. Goode, T. Szili-Torok, C. Linde, and on behalf of the REVERSE Study Group
Prevention of Disease Progression by Cardiac Resynchronization Therapy in Patients With Asymptomatic or Mildly Symptomatic Left Ventricular Dysfunction: Insights From the European Cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) Trial
J. Am. Coll. Cardiol., November 10, 2009; 54(20): 1837 - 1846.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. V. Exner
Is it Time to Expand the Use of Cardiac Resynchronization Therapy to Patients With Mildly Symptomatic Heart Failure?
J. Am. Coll. Cardiol., November 10, 2009; 54(20): 1847 - 1849.
[Full Text] [PDF]


Home page
CirculationHome page
M. St. John Sutton, S. Ghio, T. Plappert, L. Tavazzi, L. Scelsi, C. Daubert, W. T. Abraham, M. R. Gold, C. Hassager, J. M. Herre, et al.
Cardiac Resynchronization Induces Major Structural and Functional Reverse Remodeling in Patients With New York Heart Association Class I/II Heart Failure
Circulation, November 10, 2009; 120(19): 1858 - 1865.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
J. Solis, D. McCarty, R. A. Levine, M. D. Handschumacher, L. Fernandez-Friera, A. Chen-Tournoux, L. Mont, B. Vidal, J. P. Singh, J. Brugada, et al.
Mechanism of Decrease in Mitral Regurgitation After Cardiac Resynchronization Therapy: Optimization of the Force-Balance Relationship
Circ Cardiovasc Imaging, November 1, 2009; 2(6): 444 - 450.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
F. Z. Khan, M. S. Virdee, D. Gopalan, J. Rudd, T. Watson, S. P. Fynn, and D. P. Dutka
Characterization of the suitability of coronary venous anatomy for targeting left ventricular lead placement in patients undergoing cardiac resynchronization therapy
Europace, November 1, 2009; 11(11): 1491 - 1495.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
J. C. Daubert, C. Leclercq, and P. Mabo
Cardiac resynchronization therapy in combination with implantable cardioverter-defibrillator
Europace, November 1, 2009; 11(suppl_5): v87 - v92.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
P. W.X. Foley, F. Leyva, and M. P. Frenneaux
What is treatment success in cardiac resynchronization therapy?
Europace, November 1, 2009; 11(suppl_5): v58 - v65.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
E. W.K. Peng, S. Lilley, B. Knight, J. Sinclair, F. Lyall, K. MacArthur, J. C.S. Pollock, and M. H.D. Danton
Synergistic interaction between right ventricular mechanical dyssynchrony and pulmonary regurgitation determines early outcome following tetralogy of Fallot repair
Eur. J. Cardiothorac. Surg., October 1, 2009; 36(4): 694 - 702.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
D. H. Kwon, C. M. Halley, Z. B. Popovic, T. P. Carrigan, V. Zysek, R. Setser, P. Schoenhagen, S. D. Flamm, R. C. Starling, and M. Y. Desai
Gender differences in survival in patients with severe left ventricular dysfunction despite similar extent of myocardial scar measured on cardiac magnetic resonance
Eur J Heart Fail, October 1, 2009; 11(10): 937 - 944.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Y. Patwala, P. R. Woods, L. Sharp, D. F. Goldspink, L. B. Tan, and D. J. Wright
Maximizing Patient Benefit From Cardiac Resynchronization Therapy With the Addition of Structured Exercise Training: A Randomized Controlled Study
J. Am. Coll. Cardiol., June 23, 2009; 53(25): 2332 - 2339.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. M. Hawkins, M. C. Petrie, M. I. Burgess, and J. J.V. McMurray
Selecting patients for cardiac resynchronization therapy: the fallacy of echocardiographic dyssynchrony.
J. Am. Coll. Cardiol., May 26, 2009; 53(21): 1944 - 1959.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. Boveda, E. Marijon, S. Jacob, P. Defaye, J. B. Winter, A. Bulava, D. Gras, J. P. Albenque, N. Combes, D. Pavin, et al.
Incidence and prognostic significance of sustained ventricular tachycardias in heart failure patients implanted with biventricular pacemakers without a back-up defibrillator: results from the prospective, multicentre, Mona Lisa cohort study
Eur. Heart J., May 2, 2009; 30(10): 1237 - 1244.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
S. Ghio, N. Freemantle, L. Scelsi, A. Serio, G. Magrini, M. Pasotti, A. Shankar, J. G.F. Cleland, and L. Tavazzi
Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE-HF trial
Eur J Heart Fail, May 1, 2009; 11(5): 480 - 488.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
F. Z. Khan, M. S. Virdee, S. P. Fynn, and D. P. Dutka
Left ventricular lead placement in cardiac resynchronization therapy: where and how?
Europace, May 1, 2009; 11(5): 554 - 561.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J.-U. Voigt, T.-M. Schneider, S. Korder, M. Szulik, E. Gurel, W. G. Daniel, F. Rademakers, and F. A. Flachskampf
Apical transverse motion as surrogate parameter to determine regional left ventricular function inhomogeneities: a new, integrative approach to left ventricular asynchrony assessment
Eur. Heart J., April 2, 2009; 30(8): 959 - 968.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
P. W.X. Foley, S. A. Muhyaldeen, S. Chalil, R. E.A. Smith, J. E. Sanderson, and F. Leyva
Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure
Europace, April 1, 2009; 11(4): 495 - 501.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Chakir, S. K. Daya, T. Aiba, R. S. Tunin, V. L. Dimaano, T. P. Abraham, K. Jaques, E. W. Lai, K. Pacak, W.-Z. Zhu, et al.
Mechanisms of Enhanced {beta}-Adrenergic Reserve From Cardiac Resynchronization Therapy
Circulation, March 10, 2009; 119(9): 1231 - 1240.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W. Mullens, R. A. Grimm, T. Verga, T. Dresing, R. C. Starling, B. L. Wilkoff, and W.H. W. Tang
Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program.
J. Am. Coll. Cardiol., March 3, 2009; 53(9): 765 - 773.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W. Mullens, T. Verga, R. A. Grimm, R. C. Starling, B. L. Wilkoff, and W.H. W. Tang
Persistent hemodynamic benefits of cardiac resynchronization therapy with disease progression in advanced heart failure.
J. Am. Coll. Cardiol., February 17, 2009; 53(7): 600 - 607.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
Q Zhang, J W-H Fung, J Y-S Chan, G Yip, Y-Y Lam, Y-J Liang, and C-M Yu
Difference in long-term clinical outcome after cardiac resynchronisation therapy between ischaemic and non-ischaemic aetiologies of heart failure
Heart, January 15, 2009; 95(2): 113 - 118.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
D. H. Kwon, C. M. Halley, T. P. Carrigan, V. Zysek, Z. B. Popovic, R. Setser, P. Schoenhagen, R. C. Starling, S. D. Flamm, and M. Y. Desai
Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study.
J. Am. Coll. Cardiol. Img., January 1, 2009; 2(1): 34 - 44.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. Nazeri, A. Massumi, A. Rasekh, M. Saeed, C. Frank, J. M. Wilson, J. A. Lopez, and M. Razavi
Cardiac resynchronization therapy may improve symptoms of congestive heart failure in patients without electrical or mechanical dyssynchrony
Europace, January 1, 2009; 11(1): 86 - 88.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
B. Sredniawa, R. Lenarczyk, O. Kowalski, P. Pruszkowska-Skrzep, J. Kowalczyk, A. Musialik-Lydka, S. Cebula, and Z. Kalarus
Sleep apnoea as a predictor of mid- and long-term outcome in patients undergoing cardiac resynchronization therapy
Europace, January 1, 2009; 11(1): 106 - 114.
[Abstract] [Full Text] [PDF]


Home page
ESC Textbook of Cardiovascular MedicineHome page
A. Vahanian, B. Iung, L. Piérard, R. Dion, and J. Pepper
CHAPTER 21 Valvular Heart Disease
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Leclercq, P. Mabo, and J. N. Trochu
Cardiac Resynchronization for Asymptomatic or Mildly Symptomatic Heart Failure: A Bridge Too Far?
J. Am. Coll. Cardiol., December 2, 2008; 52(23): 1844 - 1846.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Linde, W. T. Abraham, M. R. Gold, M. St. John Sutton, S. Ghio, C. Daubert, and REVERSE (REsynchronization reVErses Remodeling in
Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms
J. Am. Coll. Cardiol., December 2, 2008; 52(23): 1834 - 1843.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
T Z Naqvi, A M Rafique, C Swerdlow, S Verma, R J Siegel, K Tolstrup, W Kerwin, J Goodman, D Gallik, E Gang, et al.
Predictors of reduction in mitral regurgitation in patients undergoing cardiac resynchronisation treatment
Heart, December 1, 2008; 94(12): 1580 - 1588.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
U. Bildirici, A. Vural, A. Agacdiken, T. Sahin, U. Celikyurt, T. Kilic, and D. Ural
Comparison of the effects of left vs. right ventricular pacing on left ventricular remodelling
Europace, December 1, 2008; 10(12): 1387 - 1391.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Ypenburg, R. J. van Bommel, V. Delgado, S. A. Mollema, G. B. Bleeker, E. Boersma, M. J. Schalij, and J. J. Bax
Optimal Left Ventricular Lead Position Predicts Reverse Remodeling and Survival After Cardiac Resynchronization Therapy
J. Am. Coll. Cardiol., October 21, 2008; 52(17): 1402 - 1409.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Circulation, October 7, 2008; 118(15): e523 - e661.
[Full Text] [PDF]


Home page
Eur Heart JHome page
L. Di Biase, A. Auricchio, A. Sorgente, K. Civello, C. Klersy, F. Faletra, L. Riedlbauchova, D. Patel, M. Arruda, R. A. Schweikert, et al.
The magnitude of reverse remodelling irrespective of aetiology predicts outcome of heart failure patients treated with cardiac resynchronization therapy
Eur. Heart J., October 2, 2008; 29(20): 2497 - 2505.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
T. Stanton, N. M. Hawkins, K. J. Hogg, N. E.R. Goodfield, M. C. Petrie, and J. J.V. McMurray
How should we optimize cardiac resynchronization therapy?
Eur. Heart J., October 2, 2008; 29(20): 2458 - 2472.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Kirn, A. Jansen, F. Bracke, B. van Gelder, T. Arts, and F. W. Prinzen
Mechanical discoordination rather than dyssynchrony predicts reverse remodeling upon cardiac resynchronization
Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H640 - H646.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. A. Carabello
The Current Therapy for Mitral Regurgitation
J. Am. Coll. Cardiol., July 29, 2008; 52(5): 319 - 326.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
F. W. Prinzen and A. Auricchio
Is echocardiographic assessment of dyssynchrony useful to select candidates for cardiac resynchronization therapy?: Echocardiography Is Not Useful Before Cardiac Resynchronization Therapy if QRS Duration Is Available
Circ Cardiovasc Imaging, July 1, 2008; 1(1): 70 - 78.
[Full Text] [PDF]


Home page
HeartHome page
K Khadjooi, P W Foley, S Chalil, J Anthony, R E A Smith, M P Frenneaux, and F Leyva
Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation
Heart, July 1, 2008; 94(7): 879 - 883.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
A. H.M. Jansen, F. Bracke, J. m. van Dantzig, K. H. Peels, J. C. Post, H. C.M. van den Bosch, B. van Gelder, A. Meijer, H. H.M. Korsten, J. de Vries, et al.
The influence of myocardial scar and dyssynchrony on reverse remodeling in cardiac resynchronization therapy
Eur J Echocardiogr, July 1, 2008; 9(4): 483 - 488.
[Abstract] [Full Text] [PDF]


Home page
Circ Arrhythm ElectrophysiolHome page
M. O. Sweeney and F. W. Prinzen
Ventricular Pump Function and Pacing: Physiological and Clinical Integration
Circ Arrhythm Electrophysiol, June 1, 2008; 1(2): 127 - 139.
[Full Text] [PDF]


Home page
Eur J Heart FailHome page
D. P.S. Rogers, S. Marazia, A. W. Chow, P. D. Lambiase, M. D. Lowe, M. Frenneaux, W. J. McKenna, and P. M. Elliott
Effect of biventricular pacing on symptoms and cardiac remodelling in patients with end-stage hypertrophic cardiomyopathy
Eur J Heart Fail, May 1, 2008; 10(5): 507 - 513.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Leclercq, F. Gadler, W. Kranig, S. Ellery, D. Gras, A. Lazarus, J. Clementy, E. Boulogne, J.-C. Daubert, and for the TRIP-HF (Triple Resynchronization In Paced
A Randomized Comparison of Triple-Site Versus Dual-Site Ventricular Stimulation in Patients With Congestive Heart Failure
J. Am. Coll. Cardiol., April 15, 2008; 51(15): 1455 - 1462.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. M. Borggrefe, T. Lawo, C. Butter, H. Schmidinger, M. Lunati, B. Pieske, A. R. Misier, A. Curnis, D. Bocker, A. Remppis, et al.
Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure
Eur. Heart J., April 2, 2008; 29(8): 1019 - 1028.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. Ypenburg, P. Lancellotti, L. F. Tops, E. Boersma, G. B. Bleeker, E. R. Holman, J. D. Thomas, M. J. Schalij, L. A. Pierard, and J. J. Bax
Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy
Eur. Heart J., March 2, 2008; 29(6): 757 - 765.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
P. Milliez, O. Thomas, A. Haggui, P. Schurando, P. Squara, A. Cohen-Solal, A. Mebazaa, and A. Leenhardt
Cardiac resynchronisation as a rescue therapy in patients with catecholamine-dependent overt heart failure: Results from a short and mid-term study
Eur J Heart Fail, March 1, 2008; 10(3): 291 - 297.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
T. Inage, T. Yoshida, T. Hiraki, M. Ohe, T. Takeuchi, Y. Nagamoto, Y. Fukuda, T. Gondo, and T. Imaizumi
Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatment
Europace, March 1, 2008; 10(3): 379 - 383.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. W.M. Fedak, P. M. McCarthy, and R. O. Bonow
Evolving Concepts and Technologies in Mitral Valve Repair
Circulation, February 19, 2008; 117(7): 963 - 974.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. F. Nagueh
Mechanical dyssynchrony in congestive heart failure: diagnostic and therapeutic implications.
J. Am. Coll. Cardiol., January 1, 2008; 51(1): 18 - 22.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
T V Salukhe, K Dimopoulos, R Sutton, P Poole-Wilson, M Y Henein, M Morgan, J R Clague, and D P Francis
Instantaneous effects of resynchronisation therapy on exercise performance in heart failure patients: the mechanistic role and predictive power of total isovolumic time
Heart, January 1, 2008; 94(1): 59 - 64.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Ypenburg, P. Lancellotti, L. F. Tops, G. B. Bleeker, E. R. Holman, L. A. Pierard, M. J. Schalij, and J. J. Bax
Acute Effects of Initiation and Withdrawal of Cardiac Resynchronization Therapy on Papillary Muscle Dyssynchrony and Mitral Regurgitation
J. Am. Coll. Cardiol., November 20, 2007; 50(21): 2071 - 2077.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
G. B Bleeker, C.-M. Yu, P. Nihoyannopoulos, J. de Sutter, N. Van de Veire, E. R Holman, M. J Schalij, E. E van der Wall, and J. J Bax
Optimal use of echocardiography in cardiac resynchronisation therapy
Heart, November 1, 2007; 93(11): 1339 - 1350.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Uebing, D. G. Gibson, S. V. Babu-Narayan, G. P. Diller, K. Dimopoulos, O. Goktekin, M. S. Spence, K. Andersen, M. Y. Henein, M. A. Gatzoulis, et al.
Right Ventricular Mechanics and QRS Duration in Patients With Repaired Tetralogy of Fallot: Implications of Infundibular Disease
Circulation, October 2, 2007; 116(14): 1532 - 1539.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. L. Mann, M. A. Acker, M. Jessup, H. N. Sabbah, R. C. Starling, and S. H. Kubo
Clinical Evaluation of the CorCap Cardiac Support Device in Patients With Dilated Cardiomyopathy
Ann. Thorac. Surg., October 1, 2007; 84(4): 1226 - 1235.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
M. H.M. Hessel, G. B. Bleeker, J. J. Bax, M. M. Henneman, B. den Adel, M. Klok, M.J. Schalij, D. E. Atsma, and A. van der Laarse
Reverse ventricular remodelling after cardiac resynchronization therapy is associated with a reduction in serum tenascin-C and plasma matrix metalloproteinase-9 levels
Eur J Heart Fail, October 1, 2007; 9(10): 1058 - 1063.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al.
Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association
Europace, October 1, 2007; 9(10): 959 - 998.
[Full Text] [PDF]


Home page
CirculationHome page
D. A. Kass
Highlighting the R in CRT
Circulation, September 25, 2007; 116(13): 1434 - 1436.
[Full Text] [PDF]


Home page
CirculationHome page
G. B. Bleeker, S. A. Mollema, E. R. Holman, N. Van De Veire, C. Ypenburg, E. Boersma, E. E. van der Wall, M. J. Schalij, and J. J. Bax
Left Ventricular Resynchronization Is Mandatory for Response to Cardiac Resynchronization Therapy: Analysis in Patients With Echocardiographic Evidence of Left Ventricular Dyssynchrony at Baseline
Circulation, September 25, 2007; 116(13): 1440 - 1448.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al.
Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association
Eur. Heart J., September 2, 2007; 28(18): 2256 - 2295.
[Full Text] [PDF]


Home page
Eur Heart JHome page
K. Vernooy, R. N.M. Cornelussen, X. A.A.M. Verbeek, W. Y.R. Vanagt, A. van Hunnik, M. Kuiper, T. Arts, H. J.G.M. Crijns, and F. W. Prinzen
Cardiac resynchronization therapy cures dyssynchronopathy in canine left bundle-branch block hearts
Eur. Heart J., September 1, 2007; 28(17): 2148 - 2155.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C.-M. Yu, F. Fang, Q. Zhang, G. W.K. Yip, C. M. Li, J. Y.-S. Chan, L. Wu, and J. W.-H. Fung
Improvement of Atrial Function and Atrial Reverse Remodeling After Cardiac Resynchronization Therapy for Heart Failure
J. Am. Coll. Cardiol., August 21, 2007; 50(8): 778 - 785.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
F. M. Fruhwald, A. Fahrleitner-Pammer, R. Berger, F. Leyva, N. Freemantle, E. Erdmann, D. Gras, L. Kappenberger, L. Tavazzi, J.-C. Daubert, et al.
Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony
Eur. Heart J., July 1, 2007; 28(13): 1592 - 1597.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. J. Haykowsky, Y. Liang, D. Pechter, L. W. Jones, F. A. McAlister, and A. M. Clark
A Meta-Analysis of the Effect of Exercise Training on Left Ventricular Remodeling in Heart Failure Patients: The Benefit Depends on the Type of Training Performed
J. Am. Coll. Cardiol., June 19, 2007; 49(24): 2329 - 2336.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
C. Valzania, F. Gadler, M. J. Eriksson, A. Olsson, G. Boriani, and F. Braunschweig
Electromechanical effects of cardiac resynchronization therapy during rest and stress in patients with heart failure
Eur J Heart Fail, June 1, 2007; 9(6-7): 644 - 650.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. D. Burkhardt and B. L. Wilkoff
Interventional Electrophysiology and Cardiac Resynchronization Therapy: Delivering Electrical Therapies for Heart Failure
Circulation, April 24, 2007; 115(16): 2208 - 2220.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. K. Rao, U. N. Kumar, J. Schafer, E. Viloria, D. De Lurgio, and E. Foster
Reduced Ventricular Volumes and Improved Systolic Function With Cardiac Resynchronization Therapy: A Randomized Trial Comparing Simultaneous Biventricular Pacing, Sequential Biventricular Pacing, and Left Ventricular Pacing
Circulation, April 24, 2007; 115(16): 2136 - 2144.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
B. Lichodziejewska, K. Kurnicka, K. Grudzka, J. Malysz, M. Ciurzynski, and D. Liszewska-Pfejfer
Chronic and Acute Effects of Smoking on Left and Right Ventricular Relaxation in Young Healthy Smokers
Chest, April 1, 2007; 131(4): 1142 - 1148.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
P. J. Hauptman and H. N. Sabbah
Reversal of ventricular remodeling: Important to establish and difficult to define
Eur J Heart Fail, April 1, 2007; 9(4): 325 - 328.
[Full Text] [PDF]


Home page
Eur J Heart FailHome page
M. Kubanek, I. Malek, J. Bytesnik, P. Fridl, L. Riedlbauchova, L. Karasova, V. Lanska, and J. Kautzner
Decrease in plasma B-type natriuretic peptide early after initiation of cardiac resynchronization therapy predicts clinical improvement at 12 months
Eur J Heart Fail, December 1, 2006; 8(8): 832 - 840.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. R. Bristow
Cardiac resynchronization therapy and adrenergic mechanisms
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2590 - H2591.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. B. Bleeker, E. R. Holman, P. Steendijk, E. Boersma, E. E. van der Wall, M. J. Schalij, and J. J. Bax
Cardiac Resynchronization Therapy in Patients With a Narrow QRS Complex
J. Am. Coll. Cardiol., November 8, 2006; (2006) j.jacc.2006.07.067v1.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Rivero-Ayerza, D. A.M.J. Theuns, H. M. Garcia-Garcia, E. Boersma, M. Simoons, and L. J. Jordaens
Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials
Eur. Heart J., November 2, 2006; 27(22): 2682 - 2688.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K. Thompson, G. Saab, D. Birnie, B. J.W. Chow, H. Ukkonen, K. Ananthasubramaniam, R. A. deKemp, L. Garrard, T. D. Ruddy, J. N. DaSilva, et al.
Is Septal Glucose Metabolism Altered in Patients with Left Bundle Branch Block and Ischemic Cardiomyopathy?
J. Nucl. Med., November 1, 2006; 47(11): 1763 - 1768.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. Cicoira, D. Natarajan, C. A. Henrikson, and J. Jarcho
Biventricular Pacing
N. Engl. J. Med., October 19, 2006; 355(16): 1738 - 1739.
[Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
M. Toyama, A. Usui, T. Abe, H. Oshima, T. Akita, and Y. Ueda
Mitral Valve Surgery for Dilated Cardiomyopathy with Mitral Regurgitation
Asian Cardiovasc Thorac Ann, October 1, 2006; 14(5): 371 - 376.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
A. Rubaj, P. Rucinski, K. Rejdak, K. Oleszczak, D. Duma, P. Grieb, and A. Kutarski
Biventricular versus right ventricular pacing decreases immune activation and augments nitric oxide production in patients with chronic heart failure
Eur J Heart Fail, October 1, 2006; 8(6): 615 - 620.
[Abstract] [Full Text] [PDF]